A randomized controlled trial in the role of hyperbaric levobupivacaine with intrathecal dexmedetomidine and hyperbaric levobupivacaine with intravenous dexmedetomidine as anesthetic agents
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
ABSTRACT
newlineIntroduction:
newlineSubarachnoid anaesthesia is the method that is used the most often for surgeries
newlineinvolving the bilateral lower limbs and the lower abdomen [1]. The prolongation of the
newlineimpact of subarachnoid anaesthesia is achieved by dexmedetomidine, which is a
newlineselective land#945;and#8209;2 adrenergic agonist. This is achieved by its synergistic action with local
newlineanaesthetics [2-4]. Research has shown that intrathecal and low-dose intravenous
newlineadministration of dexmedetomidine may effectively extend the blocking of sensory and
newlinemotor pathways during subarachnoid anaesthesia without causing any unattractive side
newlineeffects[4].
newlineStudy lDesign : lProspective, Randomized, Double-Blinded Study
newlinelMaterials and lMethods : The study included 90 patients (45 in leach group, assigned
newlineby lcomputer generated randomization code)
newlineGroup lA ~ (n = 45) lPatients will lreceive 3 ml lof Hyperbaric Levobupivacaine 0.5%
newline+ Intrathecal lDexmedetomidine 5 and#956;g (0.1ml)
newlinelGroup B ~ (n = 45) lPatients lwill receive 3 lml of Hyperbaric lLevobupivacaine 0.5%
newline+Intravenous lDexmedetomidine (0.5ug/kg)
newlineResults :
newlineOnset lof lsensory lblock :
newlineMean ltime for onset of lsensory lblock among lGroup A 8.68 ± 1.7 and among Group B
newline8.15 ± 1.38 which did lnot show lstatistical lsignificance lbetween both the lgroups.
newline(p lvalue gt 0.05)
newlineRegression of lsensory lblock :
newlinelMean time for regression of lsensory block level up to T 10 among Group A cases were
newline225.11± 28.88 and among Group B cases 175.57± 52.91 which was found to be
newlinelstatistically lsignificant (p value lt 0.05)
newlineOnset lof motor lblock :
newlineMean ltime of lonset of motor block of Group A 4.33 ± 1.06 and Group B 4.53 ± 1.14
newlinewhich was found to be statistically insignificant between both the groups (p value
newlinegt 0.05).
newlineRegression of motor block :
newlineMean time for regression of motor blockade among Group A cases were 210.02± 23.48
newlineand among Group B cases 162.57± 15.35 which was found to be statistically significant
newline(p value lt 0.05)
newlineDuration of analgesia:
newlineMean time for first rescue analgesia was found to be significant between the two groups.
newlineThe time for first rescue analgesia was significantly longer in Group A (5.08 ± 0.84
newlinehours) and Group B (2.86 ± 0.75 hours), which shows significant (p value 0.0001)
newlineRamsay sedation score:
newlineRamsay sedation score of the patients among the group were calculated .The higher no.
newlineof score was observed in group B in all times The p-value of Ramsay sedation score is
newlinelt 0.05 statistically significant was observed.
newlineConclusion:
newlineIt is concluded that the intravenous dexmedetomidine (0.5 and#956;g/ kg) IV along with 0.5%
newlinehyperbaric Levobupivacaine is not as effective as the intrathecal dexmedetomidine (5
newlineand#956;g) with l0.5% Hyperbaric Levobupivacaine when it comes to the adjuvant for
newlinesubarachnoid block. This is due to the favourable outcomes in terms of prolonged
newlinesensory and motor blockade, prolonged duration of analgesia, decreased rescue
newlineanalgesic requirement, and improved pain scores.
newlineKeywords : Hyperbaric Levobupivacaine , Dexmedetomidine, Subarachnoid block.
newline